Viewing Study NCT01740258


Ignite Creation Date: 2025-12-25 @ 12:24 AM
Ignite Modification Date: 2026-02-23 @ 4:55 AM
Study NCT ID: NCT01740258
Status: COMPLETED
Last Update Posted: 2021-01-26
First Post: 2012-11-30
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Bevacizumab Beyond Progression (BBP)
Sponsor: Duke University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Malignant Glioma View
None Grade 4 Malignant Glioma View
None Glioblastoma View
None Gliosarcoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None malignant glioma View
None Grade 4 malignant glioma View
None glioblastoma View
None gliosarcoma View
None adult brain tumor View